Sentence examples for ii relapse from inspiring English sources

Treatment failure included i) persisting infection under appropriate antimicrobial therapy; and/or ii) relapse after antimicrobial therapy disruption.

In the current study, we have found that increased pre-therapeutic serum levels of VEGF in 16 patients with osteosarcoma correlate with (i) high microvessel density of the primary tumour, (ii) relapse with pulmonary metastasis during the first year of treatment, and (iii) positive expression of tissue VEGF.

> -wrap-foot> (i) Peripheral T-cell lymphoma; (ii) relapsing HLH; (iii) C. difficile colitis; (iv) acute kidney injury; (v) lactic acidosis.

The transmission dynamics are driven by two processes: (i) transmission of parasites through mosquito bites; and (ii) relapsing of liver-stage hypnozoites to cause new blood-stage infections.

Enrolment criteria for patients included: (i) diagnosis of acute myeloid leukemia (AML), non-Hodgkin's lymphoma, multiple myeloma (MM), or chronic myeloid leukemia; (ii) relapsed after or refractory to previous standard treatment; (iii) Eastern Cooperative Oncology Group performance status of 0 1; and (iv) aged 20 75 years.

Importantly, up to 30% of stage II patients relapse after surgery and many of them will die due to metastatic disease.

We tested the hypothesis that selective damage to distinct subregions of the prefrontal cortex, or to the amygdala, after a short history of cocaine taking would: (i) result in compulsive cocaine seeking at a time when it would not usually be displayed; or (ii) facilitate relapse to drug seeking after abstinence.

Although standard care is frequently initially successful in early-stage cancer (stage I or II), disease relapses still occur in about 20 30%, particularly local tumour or lymph node recurrence (Vikram, 1994; Clayman et al, 1996).

During a mean follow-up time of 23 months (range: 1 106), 17% of patients with type I vs 34.8% of patients with type II tumours relapsed and/or died (P<0.001).

To the Editor: During the early 20th century, at the end of World War I, and during World War II, louseborne relapsing fever (LBRF) caused by Borrelia recurrentis was a major public health problem, especially in eastern Europe and northern Africa (1, 2 ).

Seven patients of 16 patients with initial stage I-III relapsed and six patients received palliative chemotherapy.